-
1
-
-
36849030243
-
Management of Metastatic Melanoma
-
DOI 10.1053/j.seminoncol.2007.09.008, PII S0093775407001844, Malignant Melanoma
-
Tawbi H. A., Kirkwood J. M., Management of metastatic melanoma Seminars in Oncology 2007 34 6 532 545 (Pubitemid 350236308)
-
(2007)
Seminars in Oncology
, vol.34
, Issue.6
, pp. 532-545
-
-
Tawbi, H.A.1
Kirkwood, J.M.2
-
2
-
-
38049019119
-
Safety and anti-tumor activity of sorafenib (Nexavar) in combination with other anti-cancer agents: A review of clinical trials
-
Takimoto C. H., Awada A., Safety and anti-tumor activity of sorafenib (Nexavar) in combination with other anti-cancer agents: a review of clinical trials Cancer Chemotherapy and Pharmacology 2008 61 4 535 548
-
(2008)
Cancer Chemotherapy and Pharmacology
, vol.61
, Issue.4
, pp. 535-548
-
-
Takimoto, C.H.1
Awada, A.2
-
3
-
-
0035665036
-
Progress in the development of immunotherapy for the treatment of patients with cancer
-
DOI 10.1046/j.1365-2796.2001.00911.x
-
Rosenberg S. A., Progress in the development of immunotherapy for the treatment of patients with cancer Journal of Internal Medicine 2001 250 6 462 475 (Pubitemid 34013510)
-
(2001)
Journal of Internal Medicine
, vol.250
, Issue.6
, pp. 462-475
-
-
Rosenberg, S.A.1
-
4
-
-
0038129922
-
Close monitoring and lifetime follow-up is optimal for patients with a history of melanoma
-
DOI 10.1016/S0093-7754(03)00097-6
-
Christianson D. F., Anderson C. M., Close monitoring and lifetime follow-up is optimal for patients with a history of melanoma Seminars in Oncology 2003 30 3 369 374 (Pubitemid 36706561)
-
(2003)
Seminars in Oncology
, vol.30
, Issue.3
, pp. 369-374
-
-
Christianson, D.F.1
Anderson, C.M.2
-
5
-
-
0031929106
-
Tumor vascularity, proliferation, and apoptosis in human melanoma micrometastases and macrometastases
-
Barnhill R. L., Piepkorn M. W., Cochran A. J., Flynn E., Karaoli T., Folkman J., Tumor vascularity, proliferation, and apoptosis in human melanoma micrometastases and macrometastases Archives of Dermatology 1998 134 8 991 994 (Pubitemid 28385321)
-
(1998)
Archives of Dermatology
, vol.134
, Issue.8
, pp. 991-994
-
-
Barnhill, R.L.1
Piepkorn, M.W.2
Cochran, A.J.3
Flynn, E.4
Karaoli, T.5
Folkman, J.6
-
6
-
-
0033032641
-
S100-beta, melanoma-inhibiting activity, and lactate dehydrogenase discriminate progressive from nonprogressive American Joint Committee on Cancer stage IV melanoma
-
Deichmann M., Benner A., Bock M., Jckel A., Uhl K., Waldmann V., Nher H., S100-beta, melanoma-inhibiting activity, and lactate dehydrogenase discriminate progressive from nonprogressive American Joint Committee on Cancer stage IV melanoma Journal of Clinical Oncology 1999 17 6 1891 1896 (Pubitemid 29269262)
-
(1999)
Journal of Clinical Oncology
, vol.17
, Issue.6
, pp. 1891-1896
-
-
Deichmann, M.1
Benner, A.2
Bock, M.3
Jackel, A.4
Uhl, K.5
Waldmann, V.6
Naher, H.7
-
7
-
-
4344701616
-
Diagnosing melanoma patients entering American Joint Committee on Cancer stage IV, C-reactive protein in serum is superior to lactate dehydrogenase
-
Deichmann M., Kahle B., Moser K., Wacker J., Wst K., Diagnosing melanoma patients entering American Joint Committee on Cancer stage IV, C-reactive protein in serum is superior to lactate dehydrogenase British Journal of Cancer 2004 91 4 699 702 (Pubitemid 39141627)
-
(2004)
British Journal of Cancer
, vol.91
, Issue.4
, pp. 699-702
-
-
Deichmann, M.1
Kahle, B.2
Moser, K.3
Wacker, J.4
Wust, K.5
-
8
-
-
0036446555
-
Comparison of prognostic significance of serum 5-S-cysteinyldopa, LDH and S-100B protein in stage III-IV malignant melanoma
-
Bnfalvi T., Boldizsr M., Gergye M., Gilde K., Kremmer T., Ott S., Comparison of prognostic significance of serum 5-S-cysteinyldopa, LDH and S-100B protein in stage III-IV malignant melanoma Pathology and Oncology Research 2002 8 3 183 187 (Pubitemid 35407638)
-
(2002)
Pathology Oncology Research
, vol.8
, Issue.3
, pp. 183-187
-
-
Banfalvi, T.1
Boldizsar, M.2
Gergye, M.3
Gilde, K.4
Kremmer, T.5
Otto, S.6
-
9
-
-
3042685214
-
S100 proteins as cancer biomarkers with focus on S100B in malignant melanoma
-
DOI 10.1016/j.clinbiochem.2004.05.012, PII S0009912004001353
-
Harpio R., Einarsson R., S100 proteins as cancer biomarkers with focus on S100B in malignant melanoma Clinical Biochemistry 2004 37 7 512 518 (Pubitemid 38845014)
-
(2004)
Clinical Biochemistry
, vol.37
, Issue.7
, pp. 512-518
-
-
Harpio, R.1
Einarsson, R.2
-
10
-
-
67249148924
-
LDH correlation with survival in advanced melanoma from two large, randomised trials (Oblimersen GM301 and EORTC 18951)
-
Agarwala S. S., Keilholz U., Gilles E., Bedikian A. Y., Wu J., Kay R., Stein C. A., Itri L. M., Suciu S., Eggermont A. M. M., LDH correlation with survival in advanced melanoma from two large, randomised trials (Oblimersen GM301 and EORTC 18951) European Journal of Cancer 2009 45 10 1807 1814
-
(2009)
European Journal of Cancer
, vol.45
, Issue.10
, pp. 1807-1814
-
-
Agarwala, S.S.1
Keilholz, U.2
Gilles, E.3
Bedikian, A.Y.4
Wu, J.5
Kay, R.6
Stein, C.A.7
Itri, L.M.8
Suciu, S.9
Eggermont, A.M.M.10
-
11
-
-
0028817983
-
Clinical significance of serum S100 in metastatic malignant melanoma
-
Guo H. B., Stoffel-Wagner B., Bierwirth T., Mezger J., Klingmller D., Clinical significance of serum S100 in metastatic malignant melanoma. European Journal of Cancer 1995 31 11 1898 1902
-
(1995)
European Journal of Cancer
, vol.31
, Issue.11
, pp. 1898-1902
-
-
Guo, H.B.1
Stoffel-Wagner, B.2
Bierwirth, T.3
Mezger, J.4
Klingmller, D.5
-
12
-
-
0031798536
-
The luminescence immunoassay S-100: A sensitive test to measure circulating S-100B: Its prognostic value in malignant melanoma
-
Bonfrer J. M. G., Korse C. M., Nieweg O. E., Rankin E. M., The luminescence immunoassay S-100: a sensitive test to measure circulating S-100B: its prognostic value in malignant melanoma British Journal of Cancer 1998 77 12 2210 2214 (Pubitemid 28263943)
-
(1998)
British Journal of Cancer
, vol.77
, Issue.12
, pp. 2210-2214
-
-
Bonfrer, J.M.G.1
Korse, C.M.2
Nieweg, O.E.3
Rankin, E.M.4
-
13
-
-
0033023956
-
Predictive value of serum S100B for monitoring patients with metastatic melanoma during chemotherapy and/or immunotherapy
-
DOI 10.1046/j.1365-2133.1999.02905.x
-
Hauschild A., Engel G., Brenner W., Glser R., Mnig H., Henze E., Christophers E., Predictive value of serum S100B for monitoring patients with metastatic melanoma during chemotherapy and/or immunotherapy British Journal of Dermatology 1999 140 6 1065 1071 (Pubitemid 29284578)
-
(1999)
British Journal of Dermatology
, vol.140
, Issue.6
, pp. 1065-1071
-
-
Hauschild, A.1
Engel, G.2
Brenner, W.3
Glaser, R.4
Monig, H.5
Henze, E.6
Christophers, E.7
-
14
-
-
0035015137
-
S100β is a more reliable tumor marker in peripheral blood for patients with newly occurred melanoma metastases compared with MIA, albumin and lactate-dehydrogenase
-
Krhn G., Kaskel P., Sander S., Pereira Y Waizenhfer J., Wortmann S., Leiter U., Peter R. U., S100 is a more reliable tumor marker in peripheral blood for patients with newly occurred melanoma metastases compared with MIA, albumin and lactate-dehydrogenase Anticancer Research 2001 21 2 B 1311 1316 (Pubitemid 32494139)
-
(2001)
Anticancer Research
, vol.21
, Issue.2 B
, pp. 1311-1316
-
-
Krahn, G.1
Kaskel, P.2
Sander, S.3
Pereira, Y.4
Waizenhofer, J.5
Wortmann, S.6
Leiter, U.7
Peter, R.U.8
-
15
-
-
0031718717
-
Results of interleukin-2-based treatment in advanced melanoma: A case record-based analysis of 631 patients
-
Keilholz U., Conradt C., Legha S. S., Khayat D., Scheibenbogen C., Thatcher N., Goey S. H., Gore M., Dorval T., Hancock B., Punt C. J. A., Dummer R., Avril M. F., Brcker E. B., Benhammouda A., Eggermont A. M. M., Pritsch M., Results of interleukin-2-based treatment in advanced melanoma: a case record-based analysis of 631 patients Journal of Clinical Oncology 1998 16 9 2921 2929 (Pubitemid 28417410)
-
(1998)
Journal of Clinical Oncology
, vol.16
, Issue.9
, pp. 2921-2929
-
-
Keilholz, U.1
Conradt, C.2
Legha, S.S.3
Khayat, D.4
Scheibenbogen, C.5
Thatcher, N.6
Goey, S.H.7
Gore, M.8
Dorval, T.9
Hancock, B.10
Punt, C.J.A.11
Dummer, R.12
Avril, M.-F.13
Brocker, E.B.14
Benhammouda, A.15
Eggermont, A.M.M.16
Pritsch, M.17
-
16
-
-
0029783592
-
Prognostic factors for response and survival in patients with metastatic melanoma receiving immunotherapy
-
Keilholz U., Scheibenbogen C., Sommer M., Pritsch M., Geuke A. M., Prognostic factors for response and survival in patients with metastatic melanoma receiving immunotherapy Melanoma Research 1996 6 2 173 178 (Pubitemid 26259032)
-
(1996)
Melanoma Research
, vol.6
, Issue.2
, pp. 173-178
-
-
Keilholz, U.1
Scheibenbogen, C.2
Sommer, M.3
Pritsch, M.4
Geuke, A.-M.5
-
17
-
-
0036124933
-
S-100 protein serum levels in patients with benign and malignant diseases: False-positive results related to liver and renal function
-
DOI 10.1159/000048687
-
Molina R., Navarro J., Filella X., Castel T., Ballesta A. M., S-100 protein serum levels in patients with benign and malignant diseases: false-positive results related to liver and renal function Tumor Biology 2002 23 1 39 44 (Pubitemid 34225020)
-
(2002)
Tumor Biology
, vol.23
, Issue.1
, pp. 39-44
-
-
Molina, R.1
Navarro, J.2
Filella, X.3
Castel, T.4
Ballesta, A.M.5
-
18
-
-
0031925404
-
Cellular-source of serum lactate dehydrogenase elevation in patients with thrombotic thrombocytopenic purpura
-
DOI 10.1002/(SICI)1098-1101(19 98)13:1<16::AID-JC A3>3.0.CO;2-C
-
Cohen J. A., Brecher M. E., Bandarenko N., Cellular-source of serum lactate dehydrogenase elevation in patients with thrombotic thrombocytopenic purpura Journal of Clinical Apheresis 1998 13 1 16 19 (Pubitemid 28215135)
-
(1998)
Journal of Clinical Apheresis
, vol.13
, Issue.1
, pp. 16-19
-
-
Cohen, J.A.1
Brecher, M.E.2
Bandarenko, N.3
-
19
-
-
0020470409
-
Peliosis hepatis. Report of two autopsy cases with a review of the literature
-
Asano S., Wakasa H., Kaise S., Peliosis hepatis. Report of two autopsy cases with a review of the literature Acta Pathologica Japonica 1982 32 5 861 877 (Pubitemid 13252944)
-
(1982)
Acta Pathologica Japonica
, vol.32
, Issue.5
, pp. 861-877
-
-
Asano, S.1
Wakasa, H.2
Kaise, S.3
-
20
-
-
67650951164
-
Hypoxic hepatitis: Underlying conditions and risk factors for mortality in critically ill patients
-
Fuhrmann V., Kneidinger N., Herkner H., Heinz G., Nikfardjam M., Bojic A., Schellongowski P., Angermayr B., Kitzberger R., Warszawska J., Holzinger U., Schenk P., Madl C., Hypoxic hepatitis: underlying conditions and risk factors for mortality in critically ill patients Intensive Care Medicine 2009 35 8 1397 1405
-
(2009)
Intensive Care Medicine
, vol.35
, Issue.8
, pp. 1397-1405
-
-
Fuhrmann, V.1
Kneidinger, N.2
Herkner, H.3
Heinz, G.4
Nikfardjam, M.5
Bojic, A.6
Schellongowski, P.7
Angermayr, B.8
Kitzberger, R.9
Warszawska, J.10
Holzinger, U.11
Schenk, P.12
Madl, C.13
-
22
-
-
33748310638
-
CEACAMs: Their role in physiology and pathophysiology
-
DOI 10.1016/j.ceb.2006.08.008, PII S0955067406001189
-
Kuespert K., Pils S., Hauck C. R., CEACAMs: their role in physiology and pathophysiology Current Opinion in Cell Biology 2006 18 5 565 571 (Pubitemid 44332912)
-
(2006)
Current Opinion in Cell Biology
, vol.18
, Issue.5
, pp. 565-571
-
-
Kuespert, K.1
Pils, S.2
Hauck, C.R.3
-
23
-
-
0027482854
-
Biliary glycoprotein, a potential human cell adhesion molecule, is down- regulated in colorectal carcinomas
-
DOI 10.1073/pnas.90.22.10744
-
Neumaier M., Paululat S., Chan A., Matthaes P., Wagener C., Biliary glycoprotein, a potential human cell adhesion molecule, is down- regulated in colorectal carcinomas Proceedings of the National Academy of Sciences of the United States of America 1993 90 22 10744 10748 (Pubitemid 23347119)
-
(1993)
Proceedings of the National Academy of Sciences of the United States of America
, vol.90
, Issue.22
, pp. 10744-10748
-
-
Neumaier, M.1
Paululat, S.2
Chan, A.3
Matthaes, P.4
Wagener, C.5
-
24
-
-
0030917224
-
Decreased expression of biliary glycoprotein in hepatocellular carcinomas
-
DOI 10.1002/(SICI)1097-0215(1997 0220)74:1<15::AID-IJ C3>3.0.CO;2-3
-
Tanaka K., Hinoda Y., Takahashi H., Sakamoto H., Nakajima Y., Imai K., Decreased expression of biliary glycoprotein in hepatocellular carcinomas International Journal of Cancer 1997 74 1 15 19 (Pubitemid 27157849)
-
(1997)
International Journal of Cancer
, vol.74
, Issue.1
, pp. 15-19
-
-
Tanaka, K.1
Hinoda, Y.2
Takahashi, H.3
Sakamoto, H.4
Nakajima, Y.5
Imai, K.6
-
25
-
-
7244234272
-
The tumour suppressor gene CEACAMI is completely but reversibly downregulated in renal cell carcinoma
-
DOI 10.1002/path.1657
-
Kammerer R., Riesenberg R., Weiler C., Lohrmann J., Schleypen J., Zimmermann W., The tumour suppressor gene CEACAMI is completely but reversibly downregulated in renal cell carcinoma Journal of Pathology 2004 204 3 258 267 (Pubitemid 39430084)
-
(2004)
Journal of Pathology
, vol.204
, Issue.3
, pp. 258-267
-
-
Kammerer, R.1
Riesenberg, R.2
Weiler, C.3
Lohrmann, J.4
Schleypen, J.5
Zimmermann, W.6
-
26
-
-
0036239847
-
Down-regulation of CEACAM1 in human prostate cancer: Correlation with loss of cell polarity, increased proliferation rate, and Gleason grade 3 to 4 transition
-
DOI 10.1053/hupa.2002.32218
-
Busch C., Hanssen T. A., Wagener C., Down-regulation of CEACAM1 in human prostate cancer: correlation with loss of cell polarity, increased proliferation rate, and Gleason grade 3 to 4 transition Human Pathology 2002 33 3 290 298 (Pubitemid 34461462)
-
(2002)
Human Pathology
, vol.33
, Issue.3
, pp. 290-298
-
-
Busch, C.1
Hanssen, T.A.2
Wagener, C.3
-
27
-
-
0029585326
-
Inhibition of colonic tumor cell growth by biliary glycoprotein
-
Kunath T., Ordoez-Garcia C., Turbide C., Beauchemin N., Inhibition of colonic tumor cell growth by biliary glycoprotein Oncogene 1995 11 11 2375 2382 (Pubitemid 26008415)
-
(1995)
Oncogene
, vol.11
, Issue.11
, pp. 2375-2382
-
-
Kunath, T.1
Ordonez-Garcia, C.2
Turbide, C.3
Beauchemin, N.4
-
28
-
-
0028897315
-
Tumor suppressive role of an androgen-regulated epithelial cell adhesion molecule (C-CAM) in prostate carcinoma cell revealed by sense and antisense approaches
-
Hsieh J. T., Luo W., Song W., Wang Y., Kleinerman D. I., Van N. T., Lin S. H., Tumor suppressive role of an androgen-regulated epithelial cell adhesion molecule (C-CAM) in prostate carcinoma cell revealed by sense and antisense approaches Cancer Research 1995 55 1 190 197
-
(1995)
Cancer Research
, vol.55
, Issue.1
, pp. 190-197
-
-
Hsieh, J.T.1
Luo, W.2
Song, W.3
Wang, Y.4
Kleinerman, D.I.5
Van, N.T.6
Lin, S.H.7
-
29
-
-
0037093211
-
CEACAM1 expression in cutaneous malignant melanoma predicts the development of metastatic disease
-
DOI 10.1200/JCO.2002.05.033
-
Thies A., Moll I., Berger J., Wagener C., Brmmer J., Schulze H. J., Brunner G., Schumacher U., CEACAM1 expression in cutaneous malignant melanoma predicts the development of metastatic disease Journal of Clinical Oncology 2002 20 10 2530 2536 (Pubitemid 34525740)
-
(2002)
Journal of Clinical Oncology
, vol.20
, Issue.10
, pp. 2530-2536
-
-
Thies, A.1
Moll, I.2
Berger, J.3
Wagener, C.4
Brummer, J.5
Schulze, H.-J.6
Brunner, G.7
Schumacher, U.8
-
30
-
-
0036843104
-
Expression of CEACAM1 in adenocarcinoma of the lung: A factor of independent prognostic significance
-
DOI 10.1200/JCO.2002.08.067
-
Laack E., Nikbakht H., Peters A., Kugler C., Jasiewicz Y., Edler L., Brmmer J., Schumacher U., Hossfeld D. K., Expression of CEACAM1 in adenocarcinoma of the lung: a factor of independent prognostic significance Journal of Clinical Oncology 2002 20 21 4279 4284 (Pubitemid 35266287)
-
(2002)
Journal of Clinical Oncology
, vol.20
, Issue.21
, pp. 4279-4284
-
-
Laack, E.1
Nikbakht, H.2
Peters, A.3
Kugler, C.4
Jasiewicz, Y.5
Edler, L.6
Brummer, J.7
Schumacher, U.8
Hossfeld, D.K.9
-
31
-
-
0038514856
-
Elevated expression of carcinoembryonic antigen-related cell adhesion molecule 1 promotes progression of non-small cell lung cancer
-
Sienel W., Dango S., Woelfle U., Morresi-Hauf A., Wagener C., Brmmer J., Mutschler W., Passlick B., Pantel K., Elevated expression of carcinoembryonic antigen-related cell adhesion molecule 1 promotes progression of non-small cell lung cancer Clinical Cancer Research 2003 9 6 2260 2266 (Pubitemid 36687651)
-
(2003)
Clinical Cancer Research
, vol.9
, Issue.6
, pp. 2260-2266
-
-
Sienel, W.1
Dango, S.2
Woelfle, U.3
Morresi-Hauf, A.4
Wagener, C.5
Brummer, J.6
Mutschler, W.7
Passlick, B.8
Pantel, K.9
-
32
-
-
67149131793
-
Protein expression of carcinoembryonic antigen cell adhesion molecules in benign and malignant melanocytic skin lesions
-
Gambichler T., Grothe S., Rotterdam S., Altmeyer P., Kreuter A., Protein expression of carcinoembryonic antigen cell adhesion molecules in benign and malignant melanocytic skin lesions American Journal of Clinical Pathology 2009 131 6 782 787
-
(2009)
American Journal of Clinical Pathology
, vol.131
, Issue.6
, pp. 782-787
-
-
Gambichler, T.1
Grothe, S.2
Rotterdam, S.3
Altmeyer, P.4
Kreuter, A.5
-
33
-
-
7244254254
-
CEACAM1 enhances invasion and migration of melanocytic and melanoma cells
-
Ebrahimnejad A., Streichert T., Nollau P., Horst A. K., Wagener C., Bamberger A. M., Brmmer J., CEACAM1 enhances invasion and migration of melanocytic and melanoma cells American Journal of Pathology 2004 165 5 1781 1787 (Pubitemid 39435175)
-
(2004)
American Journal of Pathology
, vol.165
, Issue.5
, pp. 1781-1787
-
-
Ebrahimnejad, A.1
Streichert, T.2
Nollau, P.3
Horst, A.K.4
Wagener, C.5
Bamberger, A.-M.6
Brummer, J.7
-
34
-
-
0037087297
-
CD66a interactions between human melanoma and NK cells: A novel class I MHC-independent inhibitory mechanism of cytotoxicity
-
Markel G., Lieberman N., Katz G., Arnon T. I., Lotem M., Drize O., Blumberg R. S., Bar-Haim E., Mader R., Eisenbach L., Mandelboim O., CD66a interactions between human melanoma and NK cells: a novel class I MHC-independent inhibitory mechanism of cytotoxicity Journal of Immunology 2002 168 6 2803 2810 (Pubitemid 34211659)
-
(2002)
Journal of Immunology
, vol.168
, Issue.6
, pp. 2803-2810
-
-
Markel, G.1
Lieberman, N.2
Katz, G.3
Arnon, T.I.4
Lotem, M.5
Drize, O.6
Blumberg, R.S.7
Bar-Haim, E.8
Mader, R.9
Eisenbach, L.10
Mandelboim, O.11
-
35
-
-
33750355389
-
Inhibition of human tumor-infiltrating lymphocyte effector functions by the homophilic carcinoembryonic cell adhesion molecule 1 interactions
-
Markel G., Seidman R., Stern N., Cohen-Sinai T., Izhaki O., Katz G., Besser M., Treves A. J., Blumberg R. S., Loewenthal R., Mandelboim O., Orenstein A., Schachter J., Inhibition of human tumor-infiltrating lymphocyte effector functions by the homophilic carcinoembryonic cell adhesion molecule 1 interactions Journal of Immunology 2006 177 9 6062 6071 (Pubitemid 44628821)
-
(2006)
Journal of Immunology
, vol.177
, Issue.9
, pp. 6062-6071
-
-
Markel, G.1
Seidman, R.2
Stern, N.3
Cohen-Sinai, T.4
Izhaki, O.5
Katz, G.6
Besser, M.7
Treves, A.J.8
Blumberg, R.S.9
Loewenthal, R.10
Mandelboim, O.11
Orenstein, A.12
Schachter, J.13
-
36
-
-
58149302763
-
Dynamic expression of protective CEACAM1 on melanoma cells during specific immune attack
-
Markel G., Seidman R., Cohen Y., Besser M. J., Sinai T. C., Treves A. J., Orenstein A., Berger R., Schachter J., Dynamic expression of protective CEACAM1 on melanoma cells during specific immune attack Immunology 2009 126 2 186 200
-
(2009)
Immunology
, vol.126
, Issue.2
, pp. 186-200
-
-
Markel, G.1
Seidman, R.2
Cohen, Y.3
Besser, M.J.4
Sinai, T.C.5
Treves, A.J.6
Orenstein, A.7
Berger, R.8
Schachter, J.9
-
37
-
-
71849114335
-
Systemic dysregulation of CEACAM1 in melanoma patients
-
Markel G., Ortenberg R., Seidman R., Sapoznik S., Koren-Morag N., Besser M. J., Bar J., Shapira R., Kubi A., Nardini G., Tessone A., Treves A. J., Winkler E., Orenstein A., Schachter J., Systemic dysregulation of CEACAM1 in melanoma patients Cancer Immunology, Immunotherapy 2010 59 2 215 230
-
(2010)
Cancer Immunology, Immunotherapy
, vol.59
, Issue.2
, pp. 215-230
-
-
Markel, G.1
Ortenberg, R.2
Seidman, R.3
Sapoznik, S.4
Koren-Morag, N.5
Besser, M.J.6
Bar, J.7
Shapira, R.8
Kubi, A.9
Nardini, G.10
Tessone, A.11
Treves, A.J.12
Winkler, E.13
Orenstein, A.14
Schachter, J.15
-
38
-
-
0023093741
-
Identification of specific cytolytic immune responses against autologous tumor in humans bearing malignant melanoma
-
Muul L. M., Spies P. J., Director E. P., Rosenberg S. A., Identification of specific cytolytic immune responses against autologous tumor in humans bearing malignant melanoma Journal of Immunology 1987 138 3 989 995 (Pubitemid 17012424)
-
(1987)
Journal of Immunology
, vol.138
, Issue.3
, pp. 989-995
-
-
Mesler Muul, L.1
Spies, P.J.2
Director, E.P.3
Rosenberg, S.A.4
-
39
-
-
0030986643
-
Autologous hapten-modified melanoma vaccine as postsurgical adjuvant treatment after resection of nodal metastases
-
Berd D., Maguire H. C., Schuchter L. M., Hamilton R., Hauck W. W., Sato T., Mastrangelo M. J., Autologous hapten-modified melanoma vaccine as postsurgical adjuvant treatment after resection of nodal metastases Journal of Clinical Oncology 1997 15 6 2359 2370 (Pubitemid 27251139)
-
(1997)
Journal of Clinical Oncology
, vol.15
, Issue.6
, pp. 2359-2370
-
-
Berd, D.1
Maguire Jr., H.C.2
Schuchter, L.M.3
Hamilton, R.4
Hauck, W.W.5
Sato, T.6
Mastrangelo, M.J.7
-
40
-
-
18444397729
-
Autologous cell vaccine as a post operative adjuvant treatment for high-risk melanoma patients (AJCC stages III and IV)
-
DOI 10.1038/sj.bjc.6600251
-
Lotem M., Peretz T., Drize O., Gimmon Z., Ad El D., Weitzen R., Goldberg H., David I. B., Prus D., Hamburger T., Shiloni E., Autologous cell vaccine as a post operative adjuvant treatment for high-risk melanoma patients (AJCC stages III and IV) British Journal of Cancer 2002 86 10 1534 1539 (Pubitemid 34628104)
-
(2002)
British Journal of Cancer
, vol.86
, Issue.10
, pp. 1534-1539
-
-
Lotem, M.1
Peretz, T.2
Drize, O.3
Gimmon, Z.4
Ad El, D.5
Weitzen, R.6
Goldberg, H.7
David, I.B.8
Prus, D.9
Hamburger, T.10
Shiloni, E.11
-
41
-
-
0017089971
-
The induction of hapten specific T cell tolerance by using hapten modified lymphoid cells. I. Characteristics of tolerance induction
-
Miller S. D., Claman H. N., The induction of hapten specific T cell tolerance by using hapten modified lymphoid cells. I. Characteristics of tolerance induction Journal of Immunology 1976 117 5
-
(1976)
Journal of Immunology
, vol.117
, Issue.5
-
-
Miller, S.D.1
Claman, H.N.2
-
42
-
-
34250766584
-
Serum markers to detect metastatic uveal melanoma
-
Barak V., Frenkel S., Kalickman I., Maniotis A. J., Folberg R., Pe'er J., Serum markers to detect metastatic uveal melanoma Anticancer Research 2007 27 4 A 1897 1900 (Pubitemid 46954694)
-
(2007)
Anticancer Research
, vol.27
, Issue.4 A
, pp. 1897-1900
-
-
Barak, V.1
Frenkel, S.2
Kalickman, I.3
Maniotis, A.J.4
Folberg, R.5
Pe'er, J.6
-
44
-
-
67349254468
-
Expression of newly identified secretory CEACAM1a isoforms in the intestinal epithelium
-
Terahara K., Yoshida M., Taguchi F., Igarashi O., Nochi T., Gotoh Y., Yamamoto T., Tsunetsugu-Yokota Y., Beauchemin N., Kiyono H., Expression of newly identified secretory CEACAM1a isoforms in the intestinal epithelium Biochemical and Biophysical Research Communications 2009 383 3 340 346
-
(2009)
Biochemical and Biophysical Research Communications
, vol.383
, Issue.3
, pp. 340-346
-
-
Terahara, K.1
Yoshida, M.2
Taguchi, F.3
Igarashi, O.4
Nochi, T.5
Gotoh, Y.6
Yamamoto, T.7
Tsunetsugu-Yokota, Y.8
Beauchemin, N.9
Kiyono, H.10
|